Raymond James Starts Insmed (INSM) at Outperform, Citing Limited Competition

On April 9, 2026, Raymond James initiated sum of Insmed Incorporated (NASDAQ:INSM) with an Outperform rating. The firm’s expert acceptable a terms people of $200 connected the stock. According to the analyst’s probe note, the aboriginal motorboat of Brinsupri has materially de-risked the company’s trajectory. The steadfast described it arsenic 1 of the strongest inflammation and immunology debuts ever and cited a monolithic underserved marketplace and constricted contention for the drug.

In a abstracted development, connected April 14, 2026, RBC Capital raised its terms people connected Insmed Incorporated (NASDAQ:INSM) from $212 to $216 portion maintaining an Outperform standing connected the company’s stock. RBC Capital told investors that, successful a survey of 50 physicians conducted by the firm, precocious restitution was noted with Brinsupri’s objective profile. Physicians expect to importantly summation prescriptions, noting that the eligible diligent colonisation is expanding dramatically. With these findings, the expert believes the drug’s beardown maturation successful the immunology marketplace is reinforced.

Druckenmiller has been 1 of the astir assertive accumulators of Insmed Incorporated (NASDAQ:INSM) crossed consecutive quarters, gathering it into a top-three position, portion Cramer believes that the banal is worthy following:

Still, this 1 is worthy keeping an oculus on.

Founded successful 1988, Insmed Incorporated (NASDAQ:INSM) is simply a planetary biopharmaceutical company. Headquartered successful New Jersey, the institution specializes successful pulmonary conditions, peculiarly those involving chronic airway inflammation and infectious diseases.

While we admit the imaginable of INSM arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 New Contenders for S&P 500 Index and Harvard University Stock Portfolio: Top 10 Stock Picks.

Disclosure: None. Follow Insider Monkey connected Google News.